Belotero® is hyaluronic acid dermal filler. It is used to improve the look of facial fold and wrinkles and restore volume, including contouring, shaping and volumising of the lips. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. You should tell your practitioner and avoid treatment with BELOTERO® if you: have had an allergic reaction to any of the ingredients; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing, inflamed or infected skin, or general infection; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, epilepsy, liver or kidney problems, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner.

Copyright © 2019. Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022 All rights reserved. Belotero ® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA

Teosyal®TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ®, TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Please consult your physician or pharmacist for more information.
Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.
* launch depending on countries registration and launch calendar
TEOSYAL KISS®, RHA KISS®, TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, , TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Please consult your physician or pharmacist for more information.
Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.

Restylane®Restylane is an unfunded Treatment that you pay for. Ask your Doctor if Restylane is right for you. Normal Doctors charges apply. Restylane is an injectable intradermal implant containing Hyaluronic acid, stabilized 20 mg/ml. Restylane is used for facial tissue augmentation and lip enhancement. Restylane should only be injected by a medical professional. Tell your medical professional if you have a bleeding disorder or if you are being treated with blood thinning medicines, or any other medicines you are taking. Precautions: Allergy to Hyaluronic acid or any active ingredients. Restylane should not be used where there is active skin disease, inflammation or related conditions. Do not use if pregnant or breastfeeding, or in children. Avoid intense heat or cold after treatment until swelling and redness have resolved. Side effects: common injection-related reactions might occur, including redness, swelling, pain, itching, bruising, tenderness or lumpiness at the implant site. Typically, these resolve in a few days to a week. Tell your medical professional if you experience any side effects. For further information ask your medical professional. Q-Med c/o Pharmacy Retailing (NZ) t/a Healthcare Logistics, Auckland 0800 174 104.